LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.56234
13.87 27.76 952 604 1.5743 1.2150
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
13.87 27.76 8 604 0.0132 -0.2441
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
13.87 27.76 1096 604 1.8124 1.2863
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
15.58 27.76 60 685 0.0875 0.1813
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
15.58 27.76 967 685 1.4105 1.1544
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
15.58 27.76 10 685 0.0146 -0.1980
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
15.58 27.76 1130 685 1.6483 1.2281
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
17.28 27.76 73 838 0.0870 0.2173
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
17.28 27.76 969 838 1.1553 1.0596
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
17.28 27.76 14 838 0.0167 -0.1300
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
17.28 27.76 1150 838 1.3711 1.1326
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
18.98 27.76 62 941 0.0659 0.1713
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
18.98 27.76 986 941 1.0477 1.0184
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
18.98 27.76 18 941 0.0191 -0.0817
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
18.98 27.76 1149 941 1.2209 1.0801
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
20.68 27.76 86 1119 0.0769 0.2362
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
20.68 27.76 1034 1119 0.9240 0.9706
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
20.68 27.76 32 1119 0.0286 0.0270
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
20.68 27.76 1182 1119 1.0563 1.0206
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
22.39 27.76 97 1305 0.0743 0.2526
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
22.39 27.76 1034 1305 0.7919 0.9178
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
22.39 27.76 31 1305 0.0237 0.0201
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
22.39 27.76 1197 1305 0.9167 0.9690
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
24.09 27.76 120 1461 0.0821 0.2918
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
24.09 27.76 1076 1461 0.7362 0.8957
MN20160318_Q01
J22